Sponsor Pipeline

Loxo Oncology, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
7
Active Trials
2
Recruiting
6
Phase 3
3
Disease Areas
Active Trials by Phase
Phase 3
6
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT05254743 A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic… Chronic Lymphocytic Leukemia Recruiting
NCT05023980 A Study of Pirtobrutinib (LOXO-305) Versus Bendamustine Plus Rituximab (BR) in Untreated… Chronic Lymphocytic Leukemia Active, Not Recruiting
NCT04965493 A Trial of Pirtobrutinib (LOXO-305) Plus Venetoclax and Rituximab (PVR) Versus Venetoclax… Chronic Lymphocytic Leukemia Active, Not Recruiting
NCT04211337 A Study of Selpercatinib (LY3527723) in Participants With RET-Mutant Medullary Thyroid… Medullary Thyroid Cancer Active, Not Recruiting
NCT04666038 Study of LOXO-305 (Pirtobrutinib) Versus Investigator's Choice (Idelalisib Plus Rituximab… Chronic Lymphocytic Leukemia Active, Not Recruiting
NCT04662255 Study of BTK Inhibitor LOXO-305 Versus Approved BTK Inhibitor Drugs in Patients With… Lymphoma, Mantle-Cell Active, Not Recruiting
Phase 2
NCT06588478 A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed… Chronic Lymphocytic Leukemia Recruiting
Disease Areas
Leukemia (5) Chronic Lymphocytic Leukemia (CLL) (5) Thyroid Cancer (1)
Get alerts when Loxo Oncology, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free